Cite
All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database
MLA
Paul Y. Kwo, et al. “All-Oral Direct-Acting Antiviral Therapy in HCV-Advanced Liver Disease Is Effective in Real-World Practice: Observations through HCV-TARGET Database.” Alimentary Pharmacology & Therapeutics, vol. 45, Oct. 2016, pp. 115–26. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bf6d2553e92fdd9cd636505f9cb2e168&authtype=sso&custid=ns315887.
APA
Paul Y. Kwo, Anna S.F. Lok, David R. Nelson, Monika Vainorius, Joseph S. Galati, Giuseppe Morelli, A. M. Di Bisceglie, Michael P. Manns, Michael Fried, Mark S. Sulkowski, G.T. Everson, Alexander Kuo, Norah A. Terrault, Joseph K. Lim, Paul J. Pockros, Robert S. Brown, K.R. Reddy, & L. Akuschevich. (2016). All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database. Alimentary Pharmacology & Therapeutics, 45, 115–126.
Chicago
Paul Y. Kwo, Anna S.F. Lok, David R. Nelson, Monika Vainorius, Joseph S. Galati, Giuseppe Morelli, A. M. Di Bisceglie, et al. 2016. “All-Oral Direct-Acting Antiviral Therapy in HCV-Advanced Liver Disease Is Effective in Real-World Practice: Observations through HCV-TARGET Database.” Alimentary Pharmacology & Therapeutics 45 (October): 115–26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bf6d2553e92fdd9cd636505f9cb2e168&authtype=sso&custid=ns315887.